OSA diagnosis goes wearable: are the latest devices ready to shine?

Study Objectives: From 2019-2023, the United States Food and Drug Administration has cleared 9 novel obstructive sleep apnea-detecting wearables for home sleep apnea testing, with many now commercially available for sleep clinicians to integrate into their clinical practices. To help clinicians comprehend these devices and their functionalities, we meticulously reviewed their operating mechanisms, sensors, algorithms, data output, and related performance evaluation literature.

Methods: We collected information from PubMed, United States Food and Drug Administration clearance documents, ClinicalTrials.